Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 4


Results: 15
    1
    2

    Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 4, p. 653, doi. 10.1007/s00262-020-02494-y
    By:
    • Mastracci, Luca;
    • Fontana, Vincenzo;
    • Queirolo, Paola;
    • Carosio, Roberta;
    • Grillo, Federica;
    • Morabito, Anna;
    • Banelli, Barbara;
    • Tanda, Enrica;
    • Boutros, Andrea;
    • Dozin, Beatrice;
    • Gualco, Marina;
    • Salvi, Sandra;
    • Romani, Massimo;
    • Spagnolo, Francesco;
    • Poggi, Alessandro;
    • Pistillo, Maria Pia
    Publication type:
    Article
    3
    4
    5
    6

    First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 4, p. 663, doi. 10.1007/s00262-020-02483-1
    By:
    • Ishihara, Mikiya;
    • Tono, Yasutaka;
    • Miyahara, Yoshihiro;
    • Muraoka, Daisuke;
    • Harada, Naozumi;
    • Kageyama, Shinichi;
    • Sasaki, Takeshi;
    • Hori, Yasuhide;
    • Soga, Norihito;
    • Uchida, Katsunori;
    • Shiraishi, Taizo;
    • Sato, Eiichi;
    • Kanda, Hideki;
    • Mizuno, Toshiro;
    • Webster, Gill A.;
    • Ikeda, Hiroaki;
    • Katayama, Naoyuki;
    • Sugimura, Yoshiki;
    • Shiku, Hiroshi
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15